Cengild Medical Berhad Cash Flow Reinvestment Rate
Cengild Medical Berhad cash flow reinvestment rate. Cengild Medical Berhad (0243) has a Cash Flow Reinvestment Rate of 3.71x as of June 2026, reinvesting RM17.23 Million (capex RM12.15 Million plus investments RM5.08 Million) from operating cash flow of RM4.65 Million. Explore Cengild Medical Berhad (0243) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cengild Medical Berhad (2020–2026)
Cash flow reinvestment rate of Cengild Medical Berhad from 2020 to 2026. Historical reinvestment intensity for Cengild Medical Berhad across 7 annual periods. Explore capital reinvestment ratio of Cengild Medical Berhad to see what proportion of operating cash flow is directed to capital expenditures.
Cengild Medical Berhad Cash Flow Reinvestment Rate by Year (2020–2026)
Cengild Medical Berhad cash flow reinvestment rate by year from 2020 to 2026. Year-by-year capital reinvestment analysis for Cengild Medical Berhad. For the full cash flow conversion analysis, see 0243 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 9.02x | RM118.17 Million | RM13.10 Million | RM81.35 Million | ▲ +175.2% |
| 2025 | 3.28x | RM52.68 Million | RM16.08 Million | RM37.26 Million | ▼ -48.3% |
| 2024 | 6.33x | RM81.91 Million | RM12.94 Million | RM15.73 Million | ▲ +65.1% |
| 2023 | 3.84x | RM52.78 Million | RM13.76 Million | RM2.13 Million | ▲ +11.3% |
| 2022 | 3.45x | RM48.43 Million | RM14.05 Million | RM427.67K | ▲ +1231.9% |
| 2021 | 0.26x | RM3.70 Million | RM14.30 Million | RM1.70 Million | ▲ +11.4% |
| 2020 | 0.23x | RM2.61 Million | RM11.24 Million | RM610.08K | — |